Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKesson
Teva
US Department of Justice
McKinsey
Mallinckrodt

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 8,812,422

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,812,422
Title:Variant database
Abstract: The invention provides a system and method for describing polymorphisms or genetic variants based on information about mutations and relationships among them. The invention uses object-oriented concepts to describe variants as variant objects and relations among those variants as variant relation object, each object being an instance of an abstract class of genomic feature and able to contain any number of other objects. Information about genetic disorders is stored in association with the object that represents the pathogenic variant. Genetic test results are used to access corresponding objects to provide a report based on variants or polymorphisms in a patient\'s genetic material.
Inventor(s): Nizzari; Marcia M. (Needham, MA), Breton; Benjamin H. (Woburn, MA), Tefft; David L. (Malden, MA), Haurie; Xavier S. (Belmont, MA)
Assignee: Good Start Genetics, Inc. (Cambridge, MA)
Application Number:13/667,575
Patent Claims:see list of patent claims

Details for Patent 8,812,422

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Good Start Genetics, Inc. (Cambridge, MA) 2032-04-09 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Good Start Genetics, Inc. (Cambridge, MA) 2032-04-09 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Good Start Genetics, Inc. (Cambridge, MA) 2032-04-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Julphar
Deloitte
UBS
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.